iBio, Inc. Annual Operating Income (Loss) in USD from 2011 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
iBio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2024.
- iBio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.11M, a 19.5% increase year-over-year.
- iBio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$15.6M, a 41.7% increase year-over-year.
- iBio, Inc. annual Operating Income (Loss) for 2024 was -$16.6M, a 43.3% increase from 2023.
- iBio, Inc. annual Operating Income (Loss) for 2023 was -$29.3M, a 1.19% increase from 2022.
- iBio, Inc. annual Operating Income (Loss) for 2022 was -$29.7M, a 4.55% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)